Graduations and Scientific Reports
|
Year |
Name |
Titel |
Grade |
|---|---|---|---|
| 2021 | Randi Istrup Juul | Characterization and use of DNA positions that are recurrently mutated across cancer patients | PhD |
| 2021 | Emma Bruun Johannsen | The Genetics of Klinefelter Syndrome: Isolation of Testicular Cells and Profiling of Circular RNA | MSc |
| 2021 | Karoline Kondrup Torstensson | Implementation of cfMeDIP-seq for investigation of methylated ctDNA in metastatic castration resistant prostate cancer | MSc |
| 2021 | Sara Kaczor Poulsen | MSc | |
| 2021 | Ann Taber | Prognostic and Predictive Biomarkers in Bladder Cancer | PhD |
| 2020 | Maibritt Nørgaard | Identification of novel biomarkers in prostate cancer to improve clinical management | PhD |
| 2020 | Marianne Trier Bjerre | DNA methylation biomarkers for prostate cancer. Identification and evaluation of blood-based methylation biomarkers | PhD |
| 2020 | Trine Strandgaard | Comprehensive Analysis of Molecular Alterations in Normal Tissue for Prediction of Disease Outcome and Treatment Response in Bladder Cancer | part A /MSc |
| 2020 | Mateo Sokač | Utilization of Artificial Intelligence Towards Precision Medicine: Interplay Between Chromosomal Instability and Immune System | part A / MSc |
| 2020 | Ea Marie Sørensen | Investigation of olaparib resistance mechanisms in advanced prostate cancer | MSc |
| 2020 | Martin Rasmussen | Investigating the tumor microenvironment of localized prostate cancer | MSc |
| 2020 | Emma K.B. Laursen | Circular RNAs in Prostate Cancer and Their Potential as Clinical Biomarkers | part A / MSc |
| 2020 | Jakob Haldrup | Identification of molecular drivers of prostate cancer aggressiveness and drug resistance | PhD |
| 2020 | Søren Klingenberg | PSMA PET/CT and new tumor markers in prostate cancer | Medical Research Year Report |
| 2020 | Trine Block Mattesen | Molecular subtyping for improved prognostication of colorectal cancer | PhD |
| 2019 | Line Bager Andersen | Assessment and validation of immune biomarker candidates for prostate cancer using tissue miceoarrays | Medical Research Year Report |
| 2019 | Trine Line Okholm | Circular RNAs in cancer and their biomarker potential | PhD |
| 2019 | Sarah Østrup Jensen | Early detection of colorectal cancer using circulating tumor DNA methylation markers | PhD |
| 2019 | Lena Marie Skindhøj Petersen | Circulating Tumor DNA as a Molecular Marker for Residual Disease and Early Detection of Relapses; Implication for recurrence monitoring in Metastatic Colorectal Cancer Patients | MSc |
| 2019 | Josephine Gladov | Characterization of a Naturally Occurring Genetic Variation Affecting the Aggressiveness of Colorectal Cancer | MSc |
| 2019 | Simone Weiss | :Evaluation of Cabazitaxel Resistance Mechanisms in Advanced Prostate Cancer Using CRISPR-Cas9 Screening | MSc |
| 2019 | Sigrid Salling Árnadóttir | Intra- and inter-tumor heterogeneity of colorectal cancer | PhD |
| 2019 | Gustav A. Poulsgaard | Localized Mutational Processes in Cancer | MSc |
| 2019 | Sia Viborg Lindskrog | Large-scale transcriptomic characterization of early-stage bladder cancer | MSc |
| 2018 | Iben Lyskjær | Evaluation of molecular markers of treatment response in metastatic colon cancer | PhD |
| 2018 | Simon Grund | MSc | |
| 2018 | Christian Stenvang | MSc | |
| 2018 | Amanda Johansen | Development of Stranded Barcode Sequencing for Ultra-Sensitive Detection of Circulating Tumor DNA in Colorectal Cancer Patients | MSc |
| 2018 | Sofie Schmøkel | Protocol Development for Single Cell Sequencing in Bladder Cancer | MSc |
| 2018 | Tenna Henriksen | Circulating Tumor DNA as a Molecular Marker for Residual Disease and Early Detection of Relapse: Implications for Adjuvant Treatment Decisions and Recurrence Monitoring | MSc |
| 2018 | Malene Blond | Exploring the association between DNA repair gene mutations and sensitivity to PARP inhibitors and Platinum Based Chemotherapy in prostate cancer cell lines | MSc |
| 2018 | Stine Hedensted | Investigating the tumor microenvironment in localized prostate cancer as a tool for improved risk stratification and individualized treatment | MSc |
| 2018 | Mai-Britt Ørntoft | The development of blood-based tests for colorectal cancer screening: How far are liquid biopsy biomarkers from clinical implementation | PhD |
| 2018 | Emil Christensen | Circulating tumor DNA as biomarkers in advanced bladder cancer | PhD |
| 2017 | Tobias Madsen | Robust Statistical Methods for Significance Evaluation and Applications in Cancer Driver Detection and Biomarker Discovery | PhD |
| 2017 | Morten Møbjerg Callesen | Porcine Models of Human Cancers | PhD |
| 2017 | Malene Juul Rasmussen | Non-coding driver detection founded on a detailed description of mutation processes in cancer | PhD |
| 2017 | Randi Istrup Pedersen | Characterization of genomic positions recurrently mutated across cancer genomes | MSc |
| 2017 | Lone Vedel Schøler | Clinical implications of analyzing circulating tumor DNA in colorectal cancer patients | PhD |
| 2017 | Mathilde Borg Houlberg Thomsen | Characterization of tumour heterogeneity and cellular subpopulations in bladder cancer | PhD |
| 2017 | Kristian K. Ambjørn Groth | Marfan syndrome: Diagnostics, epidemiology, and aortic events | PhD |
| 2016 | Ann Taber | Analysis of Tumor Markers Associated with Chemotherapy Response in Patients with Advanced Bladder Cancer | Medical Research Year Report |
| 2016 | Mia Møller | The Molecular Variations in Prostate Cancer – an Epigenetic Study with a Transcriptomic Twist | PhD |
| 2016 | Christian Trolle | The impact of female X-chromosome aneuploidies on the epigenome and transcriptome | PhD |
| 2016 | Katrine Bødker Rubach-Larsen | Small RNA Sequencing as a Method for miRNA Detection – Prognostic Biomarkers for Prostate Cancer | MSc |
| 2016 | Nadia Øgaard | Identification of Novel Long Non-Coding RNAs in Prostate Cancer by Capture RNA Sequencing And Evaluation of the Diagnostic Potential of four DNA Methylation Markers for Prostate Cancer in Plasma and Serum | MSc |
| 2016 | Siri Hundtofte Strand | The biomarker potential of DNA methylation and hydroxymethylation alterations in prostate cancer | PhD |
| 2016 | Christine Kassentoft | Identification and validation of DNA methylation biomarkers predicting response towards oxaliplatin based treatment of metastatic colorectal cancer patients | MSc |
| 2016 | Jakob Haldrup | Development of Novel Biomarkers for Prostate Cancer by Transcriptome Sequencing and CRISPR-Cas9 Genome-Editing | MSc |
| 2015 | Maibritt Nørgaard Jacobsen | Integration of DNA Methylation and RNA Expression Data: Identification of Novel Epigenetically Deregulated Biomarkers for Prostate Cancer Development and Aggressiveness | MSc |
| 2015 | Trine Block Mattesen | Molecular subtyping of colorectal cancer to improve prognostic biomarker identification | MSc |
| 2015 | Michał Świtnicki | Integrative cancer genomics analysis of gene expression and DNA methylation | PhD |
| 2015 | Martin Mørck Mortensen | The molecular signature of clinically localized prostate cancer | PhD |
| 2015 | Anne Skakkebæk | Klinefelter syndrome – brain, behavior and genetic aspects | PhD |
| 2015 | Sarah Østrup Jensen | Identification of novel blood-based biomarkers for early detection of colorectal cancer | MSc |
| 2015 | Sigrid Salling Árnadóttir | Intra-Tumor Heterogeneity in Colorectal Cancer | MSc (part A exam) |
| 2015 | Helle Kristensen | Identification of genetic and epigenetic biomarkers for prostate cancer | PhD |
| 2014 | Anne Lykke Pedersen | Characterization of ST6GALNAC3 and ZNF660 as Novel Biomarkers for Prostate Cancer | MSc |
| 2014 | Dennis K. Jeppesen | Bladder Cancer Exosomes: Isolation Procedures and Characterization of Content | PhD |
| 2014 | Kasper Faarkrog | Characterization of lncRNA expression in bladder cancer | MSc |
| 2014 | Mia Møller | Genetic and Epigenetic Heterogeneity of Prostate Cancer | MSc (part A exam) |
| 2014 | Bjarke Primdal-Bengtson | Construction of a Sleeping Beauty based Vector System for an Inducible Expression of Rab27b; a Regulator of Exosome Release | MSc |
| 2014 | Jens Reumert Laurberg |
Identification of markers for metastases and treatment response in stage T1-4 bladder tumours
|
PhD |
| 2013 | Kirsten True |
Long noncoding RNAs in colorectal cancer: in vivo expression analysis and functional characterisation in vitro
|
MSc |
| 2013 | Steffen Grann Jensen | Early detection of colorectal cancer based on microRNA in blood | PhD |
| 2013 | Mads Krogh Jensen | Significance analysis of exome and whole genome SNV data using random walk theory | MSc in bioinformatics |
| 2013 | Siri Strand | Prostate cancer biomarker discovery: DNA methylation, lncRNA expression and cell line aggression models | MSc (part A exam) |
| 2013 | Iben Lyskjær |
Functional characterization of miRNAs predicting response to chemotherapeutic treatment of metastatic colorectal cancer using a transposon-based shRNA-inducible vector system
|
MSc |
| 2013 | Niels Fristrup |
Identification of markers for progression and BCG treatment response in bladder cancer
|
PhD |
| 2013 | Trine Lindsted (CSH, USA) |
Understanding Tumor Heterogeneity in Non-Small Cell Lung Cancer
|
PhD |
| 2012 | Lene Linnet | Aberrant DNA methylation in colorectal cancer | MSc |
| 2012 | Anders Christiansen |
The Involvement of Karyopherin Alpha 2 (KPNA2) in the Proliferation, Motility and DNA Repair of Cancer Cells |
MSc |
| 2012 | Jørgen Thomas Reinert | Comprehensive DNA methylation analysis in bladder cancer: application of methylation markers for diagnosis, surveillance and prediction of recurrence | PhD |
| 2012 | Anne-Sofie Lynnerup |
Tissue microarray construktion and prostate cancer candidate markers |
Medical research year rapport |
| 2012 | Diem Nguyen Bentzon | Descriptive Epidemilogy, Molecular Biology and Genetics of Hereditary Prostate Cancer in Denmark | PhD |
| 2011 | Helle Kristensen | Epigenetic regulation and possible functional roles of miR-224, miR-452 and their host gene GABRE in prostate cancer | MSc |
| 2011 | Kristian Qvist Hansen | Evaluation of selected DNA damage response proteins as prognostic biomarkers in stage II and III colorectal cancer | Medical research year rapport |
| 2010 | Anja Holm | Functional screening identifies miRNAs that induce apoptosis and/or inhibit proliferation in colorectal cancer | MSc |
| 2010 | Christoffer Mørk Sørensen | Production of T1-4 bladder cancer tissue microarray (TMA) and test of candidate biomarkers of metastasis | Medical research year rapport |
| 2010 | Heidi Tobiasen | Identification and functional characterization of four miRNAs whose expression level is associated with the outcome of stage II CRC | MSc |
| 2010 | Troels Schepler | MicroRNAs associated with colorectal cancer and the Wnt-pathway | PhD |
| 2010 | Annette Søndergaard | The Role of miRNAs in Chemotherapy Response in Bladder Cancer | MSc |
| 2010 | Anne Sofie Brems-Eskildsen | Identification of biomarkers in bladder cancer for diagnosis and treatment response | PhD |
| 2009 | Niels Fristrup | Construction of a tissue microarray and test of survivin, maspin and cathepsin E as prognostic markers for progression to muscle invasive disease in non-muscle invasive bladder cancer | Medical research year rapport |
| 2009 | Mette Opstrup Nielsen | Identification of biomarkers for prostate cancer – the possible importance of zink finger family proteins | Medical research year rapport |
| 2009 | Hanne Bak Jensen | Characterisation of SMARCC1 – a transcription regulator deregulated in colorectal cancer | MSc |
| 2009 | Diina Ramshanker Ramanathan | miRNA detection in urine for early diagnosis of bladder cancer/miRNAs involved in the progression of bladder cancer | Medical research year rapport |
| 2008 | Asger Østerberg-Eller | Validation of biomarkers for the prognosis of stage II colorectal cancer | Medical research year rapport |
| 2008 | Rehne Hansen | Prostate cancer TMA | Medical research year rapport |
| 2007 | Sara Heebøll | Validering af kandidatgener ved udvikling af Prostata Cancer | Medical research year rapport |
| 2006 | Troels Schepeler | Wnt regulation of Clusterin | MSc |
| 2006 | Nils Magnusson | Microarray based studies of cell death, a method development and application study | PhD |
| 2006 | Birgitte Søndergaard Braüner | Identification and characterization of TNRC9 – a novel gene associated with bladder cancer | MSc |
| 2006 | Mads Aaboe Jensen | Genome-wide gene expression profiling of early bladder cancer, and functional characterization of target genes, using microarrays | PhD |
| 2006 | Sanne Harder Olesen | Identification and characterization of new potential oncogenes and tumour suppresoor genes in human colorectal cancer | PhD |
| 2005 | Kim Nielsen | Altered gene and protein expression in corneal epithelium from keratoconus patients | PhD |
| 2003 | Lars Dyskjøt Andersen | Classification of bladder cancer by micro array expression profiling - towards a general clinical use of micro arrays in cancer diagnostics | PhD |
| 2003 | Martin K Thomsen | title | MSc |
| 2003 | Casper Møller Frederiksen | Classification of colorectal cancer using microarrays | PhD |
| 2002 | Hanne Primdahl | Genomic instabilty in human bladder cancer | PhD |
| 2001 | Malene Herbsleb | From microarrays to pathways – the role of NGAL in cancer development | MSc |
| 2001 | Lise Lotte Christensen | Functional Analysis of the Human alpha-1,3/4-fucosyltransferases | PhD |
| 2000 | Mette Gaustadnes | Hyperhomocysteinemia and Thrombosis: Studies of Genetic Implications | PhD |
| 2000 | Mariann Christensen | Chromosomal Instability in Bladder and Colon Cancer | PhD |
| 1999 | Else Marie Vestergaard | Molecular genetics of Lewis and secretor genes | PhD |
| 1999 | Einar Bech | Anti-GM1 Antibodies in Acquired Demyelinating Neuropathies | PhD |
| 1997 | Peter Meldgaard | Changes in expression of glycosyltransferase genes, associated with malignant transformation of human urothelium | PhD |
| 1996 | Niels Christian Langkilde | Studies on the expression of T-(Galbeta (1-3)GalNAcalpha1-O-R) and T-like antigens in normal and pathologic human and rat urothelium | doctorate |